The human battle against viruses is an unending struggle for advantage. As we adapt and evolve to survive, pathogens evolve in response to us. This ongoing cycle is called the Red Queen hypothesis.

A New York-based venture capital firm on Tuesday unveiled a Cambridge biotech that hopes to treat a broad range of existing and emerging viruses with rapidly developed antiviral drugs. Dr. Mark ...